Literature DB >> 17973832

Immunolocalization of myocilin protein in the anterior eye of normal and primary open-angle glaucomatous dogs.

H Hart1, D A Samuelson, H Tajwar, E O MacKay, P A Lewis, M Kallberg, K N Gelatt.   

Abstract

OBJECTIVE: The presence of myocilin was investigated in a colony of Beagles, a canine model for inherited primary open-angle glaucoma (POAG). The myocilin protein was localized in the normal and glaucomatous canine eyes by immunohistochemistry and immunocytochemistry.
METHODS: Paraffin- and plastic-embedded specimens from the anterior uveas of 10 Beagles with inherited glaucoma (3 months to 13 years old) and 6 age-matched normal dogs were sectioned, and were then incubated with primary antibody, rabbit polyclonal antihuman MYOC IgG, overnight at 4 degrees C. Specimens were incubated with secondary antibody with one of the following: biotinylated link followed by peroxidase-labeled streptavidin and then by substrate-chromogen for light microscopy; fluorescent marker Texas red; or 18 nm colloidal gold-labeled goat antirabbit IgG for transmission electron microscopy.
RESULTS: With normal, pre- and early glaucomatous canine specimens, cell membranes of smooth muscle cells of the iris and ciliary body stained positively, as well as most resident stromal and vascular endothelial cells. The cytoplasm of cells within the nonpigmented ciliary epithelium of the ciliary body processes stained intensely, being weaker along the pars plana. Trabecular meshwork (TM) cells and surrounding extracellular matrix labeled, as well as the sclera adjacent to the angular aqueous plexus. In specimens with moderate and advanced glaucoma, greater intensity of staining was observed within TM cells and adjacent sclera, and portions of the nonpigmented epithelium of the ciliary processes. Fibrinous material labeled intensely within the posterior chamber.
CONCLUSIONS: Myocilin in the normal and glaucomatous canine eye was successfully immunolocalized. These findings with regard to the normal eye are nearly identical to those previously reported in humans, and support the original hypothesis that there is an increase in both accumulation and localization of myocilin in glaucomatous canine eyes. It also supports the possibility that changes in the activity of myocilin within the aqueous humor outflow pathway of individuals with spontaneous glaucoma are associated with the rise of intraocular pressure and subsequent development of this disease, but may not be the primary event in the initial raise in intraocular pressure in POAG in the Beagle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17973832     DOI: 10.1111/j.1463-5224.2007.00517.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  5 in total

Review 1.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

2.  Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.

Authors:  Sarojini Vijayasekaran; Ian L McAllister; William H Morgan; Kanishka R Mendis; Paul G McMenamin; Stephen J Cringle; Dao-Yi Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-23       Impact factor: 3.117

3.  Aqueous humor rapidly stimulates myocilin secretion from human trabecular meshwork cells.

Authors:  Zachary T Resch; Cheryl R Hann; Kimberly A Cook; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2010-10-07       Impact factor: 3.467

4.  Bovine posterior limbus: an evaluation of an alternative source for corneal endothelial and trabecular meshwork stem/progenitor cells.

Authors:  Wing Yan Yu; Ian Grierson; Carl Sheridan; Amy Cheuk-Yin Lo; David Sai-Hung Wong
Journal:  Stem Cells Dev       Date:  2014-12-22       Impact factor: 3.272

5.  Overexpression of myocilin in the Drosophila eye activates the unfolded protein response: implications for glaucoma.

Authors:  Mary Anna Carbone; Julien F Ayroles; Akihiko Yamamoto; Tatiana V Morozova; Steven A West; Michael M Magwire; Trudy F C Mackay; Robert R H Anholt
Journal:  PLoS One       Date:  2009-01-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.